September 1, 2024
Referencias
1. Averna M, Banach M, Bruckert E, et al. Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Athero sclerosis Society Task Force. Atherosclerosis. 2021;325:99-109. doi:10.1016/j.atherosclerosis.2021.03.039.
